ReviewNature reviews. Immunology2010
Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes.
Bart O Roep et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
37 papers cite it
this paperpooled ittrialcites it